(a) | by deleting paragraph 1 and substituting the following paragraph:“1. The following substances and products, namely:(1) | 1-Benzylpiperazine (also known as BZP) | (2) | 4-Bromo-2,5-dimethoxy-α-methylphenethylamine (also known as Brolamfetamine or DOB) | (3) | 4-Bromo-2,5-dimethoxyphenethylamine (also known as 2C-B) | (4) | Bufotenine | (5) | Cannabinol | (6) | Cannabinol derivatives | (7) | Cannabis and cannabis resin | (8) | Cathinone | (9) | Coca leaf | (10) | Concentrate of poppy-straw | (11) | N,N-Diethyltryptamine | (12) | 2,5-Dimethoxy-4,α-dimethylphenethylamine | (13) | 2,5-Dimethoxy-α-methylphenethylamine | (14) | N,α-Dimethyl-3,4-(methylenedioxy)phenethylamine (also known as MDMA) | (15) | 3-(1,2-Dimethylheptyl)-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran | (16) | N,N-Dimethyltryptamine | (17) | 4-Ethyl-2,5-dimethoxy-α-methylphenethylamine | (18) | N-Ethyl-α-methyl-3,4-(methylenedioxy)phenethylamine (also known as MDEA) | (19) | Eticyclidine | (20) | Etryptamine | (21) | 1-Hydroxy-3-pentyl-6a,7,10,10a-tetrahydro-6,6,9-trimethyl-6-H-dibenzo[b,d]pyran | (22) | Lysergamide | (23) | Lysergide and other N-alkyl derivatives of lysergamide | (24) | Mescaline | (25) | 3-Methoxy-α-methyl-4,5-(methylenedioxy)phenethylamine | (26) | p-Methoxy-α-methylphenethylamine | (27) | N-Methyl-α-ethyl-3,4-(methylenedioxy)phenethylamine (also known as MBDB) | (28) | N-[α-Methyl-3,4-(methylenedioxy)phenethyl]hydroxylamine | (29) | α-Methyl-3,4-(methylenedioxy)phenethylamine (also known as Tenamfetamine or MDA) | (30) | 4-Methylaminorex | (31) | Psilocin | (32) | Psilocybine | (33) | Rolicyclidine | (34) | Tenocyclidine | (35) | 1-(3-Trifluoromethylphenyl)piperazine (also known as TFMPP) | (36) | 3,4,5-Trimethoxy-α-methylphenethylamine”; |
|
|
|
(b) | by deleting “Bk-MDDMA” in item (1) of paragraph 15 and substituting “bk-MDDMA”; |
(c) | by inserting, immediately after item (8) of paragraph 15, the following items: | 1-(4-Bromophenyl)-2-(methylamino)propan-1-one (also known as 4-Bromomethcathinone or Brephedrone or 4-BMC) |
| | 1-(4-Chlorophenyl)-2-(methylamino)propan-1-one (also known as 4-Chloromethcathinone or Clephedrone or 4-CMC)”; |
|
|
|
(d) | by deleting items (10) and (11) of paragraph 15 and substituting the following items: | 1-(3,4-Dimethylphenyl)-2-(methylamino)propan-1-one (also known as 3,4-Dimethylmethcathinone or 3,4-DMMC) |
| | 2-(Ethylamino)-1-(4-fluorophenyl)propan-1-one (also known as 4-Fluoroethcathinone or 4-FEC) |
| | 2-(Ethylamino)-1-(4-methylphenyl)propan-1-one (also known as 4-Methylethcathinone or 4-MEC)”; |
|
|
|
(e) | by deleting items (15) and (16) of paragraph 15 and substituting the following items: | 1-(4-Ethylphenyl)-2-(methylamino)propan-1-one (also known as 4-Ethylmethcathinone or 4-EMC) |
| | 1-(4-Fluorophenyl)-2-(methylamino)propan-1-one (also known as 4-Fluoromethcathinone or Flephedrone or 4-FMC) |
| | 1-(4-Fluorophenyl)-2-(pyrrolidin-1-yl)pentan-1-one (also known as 4-Fluoro-α-PVP) |
| | 1-(4-Methoxyphenyl)-2-(methylamino)propan-1-one (also known as 4-Methoxymethcathinone or Methedrone or bk-PMMA or PMMC)”; |
|
|
|
(f) | by deleting item (21) of paragraph 15 and substituting the following item: | 1-(4-Methylphenyl)-2-(methylamino)propan-1-one (also known as 4-Methylmethcathinone or Mephedrone or 4-MMC)”; |
|
|
|
(g) | by deleting item (1) of paragraph 17 and substituting the following items: | N-(1-Adamantyl)-5-fluoropentyl-1H-indazole-3-carboxamide (also known as 5-Fluoro-APINACA or 5F-AKB48) and its fluoro positional isomers in the pentyl group |
| | N-(1-Adamantyl)-5-fluoropentyl-1H-indole-3-carboxamide (also known as 5-Fluoro-APICA or STS-135) and its fluoro positional isomers in the pentyl group |
| | N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide (also known as APINACA)”; |
|
|
|
(h) | by inserting, immediately after item (2) of paragraph 17, the following items: | N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (also known as AB-FUBINACA) and its fluoro positional isomers in the phenyl ring |
| | 4-(2-Aminopropyl)benzofuran (also known as 4-APB)”; |
|
|
|
(i) | by inserting, immediately after item (4) of paragraph 17, the following items: | 7-(2-Aminopropyl)benzofuran (also known as 7-APB) |
| | 4-(2-Aminopropyl)-2,3-dihydrobenzofuran (also known as 4-APDB)”; |
|
|
|
(j) | by inserting, immediately after item (6) of paragraph 17, the following items: | 7-(2-Aminopropyl)-2,3-dihydrobenzofuran (also known as 7-APDB) |
| | 2-(4-Bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (also known as 25B-NBOMe)”; |
|
|
|
(k) | by inserting, immediately after item (8) of paragraph 17, the following item: | 2-(4-Chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (also known as 25C-NBOMe)”; |
|
|
|
(l) | by inserting, immediately after item (10) of paragraph 17, the following item: | 3,4-Dichloro-N-{[1-(dimethylamino)cyclohexyl]methyl}benzamide (also known as AH-7921) and its dichloro positional isomers in the phenyl ring”; |
|
|
|
(m) | by inserting, immediately after item (15) of paragraph 17, the following item: | 2-(2,5-Dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (also known as 25H-NBOMe)”; |
|
|
|
(n) | by deleting items (20), (21) and (22) of paragraph 17 and substituting the following items: | [1-(5-Fluoropent-1-yl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone (also known as XLR-11 or 5-Fluoro-UR-144) and its fluoro positional isomers in the pentyl group |
| | 1-(4-Fluorophenyl)piperazine (also known as 4-Fluorophenylpiperazine or 4-FPP) and its fluoro positional isomers in the phenyl ring |
| | 1-(4-Fluorophenyl)propan-2-amine (also known as 4-Fluoroamphetamine or 4-FA) and its fluoro positional isomers in the phenyl ring”; |
|
|
|
(o) | by inserting, immediately after item (27) of paragraph 17, the following item: | 2-(4-Iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (also known as 25I-NBOMe)”; |
|
|
|
(p) | by deleting items (29), (30) and (31) of paragraph 17 and substituting the following items: | N-Methyl-1-(4-fluorophenyl)propan-2-amine (also known as 4-Fluoromethamphetamine or 4-FMA) and its fluoro positional isomers in the phenyl ring |
| | N-Methyl-1-(4-methoxyphenyl)propan-2-amine (also known as 4-Methoxymethamphetamine or para-Methoxymethamphetamine or PMMA) and its methoxy positional isomers in the phenyl ring |
| | N-Methyl-1-(4-methylphenyl)propan-2-amine (also known as 4-Methylmethamphetamine or 4-MMA) and its methyl positional isomers in the phenyl ring”; and |
|
|
|
(q) | by inserting, immediately after item (38) of paragraph 17, the following items: | Quinolin-8-yl 1-(cyclohexylmethyl)-1H-indole-3-carboxylate (also known as BB-22 or QUCHIC) |
| | Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (also known as 5-Fluoro-PB-22 or 5-Fluoro-QUPIC) and its fluoro positional isomers in the pentyl group |
| | Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate (also known as PB-22 or QUPIC)”. |
|
|
|